Cardiovascular Imaging Systems
This article was originally published in The Gray Sheet
Executive Summary
Completes secondary offering, netting approximately $5.2 mil. from the sale of 1 mil. shares at $6 each. The firm will use the proceeds primarily for research and development. CVIS says that it currently is supporting several studies related to its intravascular imaging technology (see story, p. 25). The firm also is working on the development of additional catheters for intravascular diagnostic and combined imaging/angioplasty uses. Montgomery Securities and Volpe, Welty & Company managed the offering, which initially was to be for 2 mil. shares ("The Gray Sheet" Feb. 1, p. 14).